Patent · US Active

Reprogramming of aged adult stem cells

US11286463B2 · kind B2 · utility

0Cited by
11References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 26, 2015
Grant dateMar 29, 2022
Priority date
Expiry dateOct 26, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2500/84
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method comprising (a) obtaining young adult stem cells (YASC) from a first subject; (b) lysing the YASC to generate a lysate comprising an intracellular matrix (ICM) and other cellular components; (c) filtering the lysate through a filter having a membrane size of equal to or less than 0.4 micron to obtain a filtrate; and (d) applying the filtrate to a culture of aged adult stem cells (AASC) for a time period ranging from about 24 hours to about 30 days to generate a reprogrammed AASC (R-AASC) wherein the AASC were obtained from a second subject and wherein the R-AASC when infused into a breast cancer stem model results in a reduced number of breast cancer cells in bone marrow in comparison to a breast cancer stem model having AASC that have not been reprogrammed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.